Summary of the Current Status of African Swine Fever Vaccine Development in China
- PMID: 37112673
- PMCID: PMC10145671
- DOI: 10.3390/vaccines11040762
Summary of the Current Status of African Swine Fever Vaccine Development in China
Abstract
African swine fever (ASF) is a highly lethal and contagious disease of domestic pigs and wild boars. There is still no credible commercially available vaccine. The only existing one, issued in Vietnam, is actually used in limited quantities in limited areas, for large-scale clinical evaluation. ASF virus is a large complex virus, not inducing full neutralizing antibodies, with multiple genotypes and a lack of comprehensive research on virus infection and immunity. Since it was first reported in China in August 2018, ASF has spread rapidly across the country. To prevent, control, further purify and eradicate ASF, joint scientific and technological research on ASF vaccines has been carried out in China. In the past 4 years (2018-2022), several groups in China have been funded for the research and development of various types of ASF vaccines, achieving marked progress and reaching certain milestones. Here, we have provided a comprehensive and systematic summary of all of the relevant data regarding the current status of the development of ASF vaccines in China to provide a reference for further progress worldwide. At present, the further clinical application of the ASF vaccine still needs a lot of tests and research accumulation.
Keywords: African swine fever; live attenuated vaccine; live vector vaccine; subunit vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Current efforts towards safe and effective live attenuated vaccines against African swine fever: challenges and prospects.Infect Dis Poverty. 2021 Dec 24;10(1):137. doi: 10.1186/s40249-021-00920-6. Infect Dis Poverty. 2021. PMID: 34949228 Free PMC article.
-
Research progress on live attenuated vaccine against African swine fever virus.Microb Pathog. 2021 Sep;158:105024. doi: 10.1016/j.micpath.2021.105024. Epub 2021 Jun 3. Microb Pathog. 2021. PMID: 34089790 Review.
-
Current State of Global African Swine Fever Vaccine Development under the Prevalence and Transmission of ASF in China.Vaccines (Basel). 2020 Sep 15;8(3):531. doi: 10.3390/vaccines8030531. Vaccines (Basel). 2020. PMID: 32942741 Free PMC article. Review.
-
African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives.Viruses. 2022 Sep 13;14(9):2021. doi: 10.3390/v14092021. Viruses. 2022. PMID: 36146827 Free PMC article. Review.
-
African swine fever vaccines: a promising work still in progress.Porcine Health Manag. 2020 Jul 2;6:17. doi: 10.1186/s40813-020-00154-2. eCollection 2020. Porcine Health Manag. 2020. PMID: 32626597 Free PMC article. Review.
Cited by
-
Advanced Strategies for Developing Vaccines and Diagnostic Tools for African Swine Fever.Viruses. 2023 Oct 28;15(11):2169. doi: 10.3390/v15112169. Viruses. 2023. PMID: 38005846 Free PMC article. Review.
-
The attenuated African swine fever vaccine HLJ/18-7GD provides protection against emerging prevalent genotype II variants in China.Emerg Microbes Infect. 2024 Dec;13(1):2300464. doi: 10.1080/22221751.2023.2300464. Epub 2024 Jan 22. Emerg Microbes Infect. 2024. PMID: 38164797 Free PMC article.
-
Stability of a surrogate African swine fever-like algal virus in corn- and soybean-based feed ingredients during extended storage and in vitro digestion processes.Front Vet Sci. 2024 Nov 27;11:1498977. doi: 10.3389/fvets.2024.1498977. eCollection 2024. Front Vet Sci. 2024. PMID: 39664890 Free PMC article.
-
Challenging boundaries: is cross-protection evaluation necessary for African swine fever vaccine development? A case of oral vaccination in wild boar.Front Immunol. 2024 Oct 1;15:1388812. doi: 10.3389/fimmu.2024.1388812. eCollection 2024. Front Immunol. 2024. PMID: 39411716 Free PMC article.
References
-
- Manso Ribeiro J., Nunes Petisca J.L., Lopes Frazao F., Sobral M. Vaccination contre la peste porcine africaine. Bull. De L’office Int. Des Epizoot. 1963;60:921–937.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous